European Journal of Internal Medicine
Volume 18, Issue 4 , Pages 304-308 , July 2007

Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae

  • T. Arnhjort

      Affiliations

    • Department of Accident and Emergency Medicine, Stockholm Söder Hospital, SE-118 83, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 8 6162081; fax: +46 8 6162137.
    • ,
  • L.M. Persson

      Affiliations

    • Department of Clinical Physiology, Karolinska Institutet at Stockholm Söder Hospital, Stockholm, Sweden
    • ,
  • S. Rosfors

      Affiliations

    • Department of Clinical Physiology, Karolinska Institutet at Stockholm Söder Hospital, Stockholm, Sweden
    • ,
  • U. Ludwigs

      Affiliations

    • Department of Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • G. Lärfars

      Affiliations

    • Department of Internal Medicine, Karolinska Institutet at Stockholm Söder Hospital, Stockholm, Sweden

Received 26 March 2006 ,Revised 21 October 2006 ,Accepted 14 December 2006.

References 

  1. Lindblad B, Bornmyr S, Kullendorff B, Bergqvist D. Venous haemodynamics of the upper extremity after subclavian vein thrombosis. Vasa. 1990;19:218–222
  2. Prandoni P, Bernardi E. Upper extremity deep vein thrombosis. Curr Opin Pulm Med. 1999;5:222–226
  3. Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation. 2002;106:1874–1880
  4. Elman EE, Kahn SR. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2005. 2006;117:609–14.
  5. Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviu MJ, Gennari L, et al. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Am J Hematol. 2004;76:330–337
  6. Baarslag HJ, Koopman MM, Hutten BA, Linthorst Homan MW, Buller HR, Reekers JA, et al. Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome. Eur J Intern Med. 2004;15:503–507
  7. Villalta S, Bagatella P. Piccioli: assessment of validity and reproducibility of a clinical scale for the post thrombotic syndrome (abstract). Heamostasis. 1994;24(suppl 1):158a
  8. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144–1148
  9. Atroshi I, Gummesson C, Andersson B, Dahlgren E, Johansson A. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: reliability and validity of the Swedish version evaluated in 176 patients. Acta Orthop Scand. 2000;71:613–618
  10. Freyschuss U. Comparison between arm and leg exercise in women and men. Scand J Clin Lab Invest. 1975;35:795–800
  11. McCann SJ, Gillingwater S, Keevil BG, Cooper DP, Morris MR. Measurement of total homocysteine in plasma and blood spots using liquid chromatography–tandem mass spectrometry: comparison with the plasma Abbott IMx method. Ann Clin Biochem. 2003;40:161–165
  12. Godfrey K. Statistics in practice. Comparing the means of several groups. N Engl J Med. 1985;313:1450–1456
  13. Lindblad B, Tengborn L, Bergqvist D. Deep vein thrombosis of the axillary–subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg. 1988;2:161–165
  14. Cromwell DL. Effort thrombosis of the subclavian and axillary veins: review of the literature. Ann Intern Med. 1960;52:1337–1343
  15. Ellis MH, Manor Y, Witz M. Risk factors and management of patients with upper limb deep vein thrombosis. Chest. 2000;117:43–46
  16. Hood DB, Kuehne J, Yellin AE, Weaver FA. Vascular complications of thoracic outlet syndrome. Am Surg. 1997;63:913–917
  17. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation. 2004;110:566–570
  18. Heron E, Lozinguez O, Alhenc-Gelas M, Emmerich J, Fiessinger JN. Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med. Feb 14 2000;160:382–386
  19. Heron E, Lozinguez O, Emmerich J, Laurina C, Fiessinger JN. Long-term sequelae of spontaneous axillary–subclavian venous thrombosis. Ann Intern Med. 1999;131:510–513
  20. Samuelsson E, Hägg S. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand. 2004;83:674–681
  21. Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 2003;330:31–55
  22. Bertina RM. Elevated clotting factor levels and venous thrombosis. Pathophysiol Haemost Thromb. 2003;33:395–400
  23. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164:17–26
  24. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost. 2005;93:499–502
  25. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:I9–I16
  26. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647–654

PII: S0953-6205(07)00054-4

doi: 10.1016/j.ejim.2006.12.005

European Journal of Internal Medicine
Volume 18, Issue 4 , Pages 304-308 , July 2007

Article Tools

* Image Usage & Resolution